Article
Generation of two induced pluripotent stem cell lines from hereditary amyloidosis patients with polyneuropathy carrying heterozygous transthyretin (TTR) mutation.
Stem cell research - 1 Feb 2024
Melesio Juan, Bonilauri Bernardo, Li Audrey, Pang Paul D, Liao Ronglih, Witteles Ronald M, Wu Joseph C, Sallam Karim
Abstract excerpt
Hereditary transthyretin amyloidosis with polyneuropathy (ATTR-PN) results from specific TTR gene mutations. In this study, we generated two induced pluripotent stem cell (iPSC) lines derived from ATTR-PN patients with heterozygous TTR gene mutations (Ala97Ser and Phe64Leu). These iPSC lines exhibited normal morphology, karyotype, high pluripotency marker expression, and differentiation into cells representing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
